Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Purpose of Health Records I01:11

Purpose of Health Records I

1.7K
The vital purpose of health records is to provide a complete and accurate account of a patient's medical history, including communication, diagnostic and therapeutic orders, care planning, research, and quality review.
Here's a breakdown of how health records serve these purposes:
1.7K
Standards of Care II01:19

Standards of Care II

1.0K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.0K
Standards of Care I01:22

Standards of Care I

1.0K
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.0K
Purpose of Health Records II01:19

Purpose of Health Records II

1.4K
Health records serve various essential purposes in the healthcare system. Here are some key purposes:
1.4K
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

837
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
837
Blinding01:11

Blinding

3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Clinic to Community: Deploying Harm Reduction Vending Machines Across a Veterans Affairs System.

Journal of public health management and practice : JPHMP·2026
Same author

Payers' Views on Insurance Coverage for Confirmatory Diagnostics After a Noncovered Multicancer Early Detection (MCED) Test.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

The potential survival gain and cost-effectiveness of circulating tumor DNA-guided treatment switching in advanced non-small cell lung cancer: A simulation modeling study.

The journal of liquid biopsy·2026
Same author

Diagnostics investments and disease burden.

Science (New York, N.Y.)·2026
Same author

Meeting Veterans Where They Are: Harm Reduction Supply Distribution via Vending Machines.

Substance use & addiction journal·2026
Same author

Pharmacist-Led Fentanyl Test Strip Education and Distribution for Veterans in Substance Use Treatment: A Quality Improvement Project.

Substance use & misuse·2026
Same journal

National Health Expenditure Projections, 2025-34: Strong Utilization Growth Initially, Legislative Impacts Later.

Health affairs (Project Hope)·2026
Same journal

State Medicaid Programs Face Increased Spending On Medicare Premiums.

Health affairs (Project Hope)·2026
Same journal

Medicaid Tobacco And Nicotine Cessation Treatment Rates Remained Low, 2019-24.

Health affairs (Project Hope)·2026
Same journal

Third-Party Convener Firms And The Rise Of Geographically Dispersed, High-Earning Medicare ACOs.

Health affairs (Project Hope)·2026
Same journal

The Opacity Of Price Transparency.

Health affairs (Project Hope)·2026
Same journal

Pre-Claim Review And Traditional Medicare Home Health Spending: Evidence From 4 States.

Health affairs (Project Hope)·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Use Of Independent Medical Review: Almost One-Half Of Coverage Denials Overturned.

Grace A Lin1, Janet M Coffman2, Michael P Douglas3

  • 1Grace A. Lin (grace.lin@ucsf.edu), University of California San Francisco, San Francisco, California.

Health Affairs (Project Hope)
|December 10, 2025
PubMed
Summary
This summary is machine-generated.

Independent medical reviews overturn nearly half of health insurance denials, including one-third of cancer genetic testing appeals. This data highlights crucial insights into insurance coverage and appeals processes.

More Related Videos

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

24.3K
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

15.8K

Related Experiment Videos

Last Updated: Jan 9, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

24.3K
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

15.8K

Area of Science:

  • Health Services Research
  • Medical Policy
  • Health Insurance

Background:

  • Independent medical review (IMR) provides valuable data on health insurance coverage.
  • IMR appeals are an underutilized resource for understanding coverage denials.
  • Analyzing IMR data can illuminate trends in health plan denials and overturn rates.

Purpose of the Study:

  • To analyze the outcomes of independent medical reviews for health insurance coverage denials.
  • To quantify the rate at which coverage denials are overturned through IMR.
  • To examine specific trends in cancer genetic testing denials and overturns.

Main Methods:

  • Retrospective analysis of independent medical review data from four states.
  • Data collected for the period 2019-2023.
  • Categorization of denials by type, including cancer genetic testing, and analysis of overturn rates.

Main Results:

  • Approximately 50% of all health plan coverage denials reviewed independently were overturned.
  • One-third of denials specifically for cancer genetic testing were overturned.
  • Significant variation in overturn rates was observed based on state, cancer type, and specific test.

Conclusions:

  • Independent medical review is a critical data source for understanding insurance coverage.
  • Overturn rates suggest potential issues with initial health plan coverage decisions.
  • Cancer genetic testing denials show variability, necessitating further investigation into coverage criteria.